United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded May 5, 2026 · Filed May 6, 2026

On May 5, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$576.24 for US$5.47M under a trading plan, leaving 40,513 shares. Filed May 6, 2026 (Form 4).

Sold
9,500 shares
Price
US$576.24 average (US$567.27 to US$581.68)
Value
US$5.47M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 5, 2026Common StockOption exercise9,500US$146.0350,013Direct
May 5, 2026Common StockSale40US$567.2749,973Direct
May 5, 2026Common StockSale240US$569.0149,733Direct
May 5, 2026Common StockSale240US$570.4149,493Direct
May 5, 2026Common StockSale445US$571.1249,048Direct
May 5, 2026Common StockSale780US$572.1748,268Direct
May 5, 2026Common StockSale677US$573.4647,591Direct
May 5, 2026Common StockSale1,267US$574.3146,324Direct
May 5, 2026Common StockSale680US$575.3845,644Direct
May 5, 2026Common StockSale250US$576.5545,394Direct
May 5, 2026Common StockSale1,217US$577.3944,177Direct
May 5, 2026Common StockSale1,653US$578.4842,524Direct
May 5, 2026Common StockSale678US$579.3741,846Direct
May 5, 2026Common StockSale504US$580.2241,342Direct
May 5, 2026Common StockSale829US$581.6840,513Direct

Source

View original at SEC

Related